In the presence of IL-6/sIL-6R, the anti-proliferative effects of RLE in both L929 and MIHA lines were weak (Fig. 2C,D) and less potent than in RA-FLS (Fig. 2A,B). The gene discussed is IL6; the disease is rheumatoid arthritis.